Share on LinkedInShare on LinkedIn

ARTICLE · 15 JULY 2020

COVID-19: Accelerated Examination Of Patent Applications For Small Entities

McMillan LLP
McMillan LLP
Contributor
McMillan LLP

McMillan LLP

The firm : McMillan LLP is one of Canada’s leading national law firms with offices in Montreal,...

View firm profile
Explore more from McMillan LLP

On July 7, 2020, the Canadian Intellectual Property Office announced a pilot process to accelerate the examination of Canadian patent applications describing technologies related to medical...

CanadaIntellectual Property

On July 7, 2020, the Canadian Intellectual Property Office announced a pilot process to accelerate the examination of Canadian patent applications describing technologies related to medical products and processes (the “Pilot Process”).1  Technologies of interest under the Pilot Process include those that are currently, or have been, subject to a Health Canada approval process (to access a list of example processes, please click on the relevant link provided in the footnotes).2

In order to qualify for the Pilot Process, the following criteria must be satisfied:

  • the applicant listed on the patent application describing technology related to medical products and processes is a “small entity”3;

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The foregoing provides only an overview and does not constitute legal advice. Readers are cautioned against making any decisions based on this material alone. Rather, specific legal advice should be obtained.

© McMillan LLP 2025

See more popular content from